1. AHRO : Austin Health Research Online
  2. Austin Health research
  3. Journal articles
Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/31873
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJanmohamed, Mubeen-
dc.contributor.authorHakeem, Haris-
dc.contributor.authorOoi, Suyi-
dc.contributor.authorHakami, Suhailah-
dc.contributor.authorVu, Lily-
dc.contributor.authorPerucca, Piero-
dc.contributor.authorO'Brien, Terence J-
dc.contributor.authorAntonic-Baker, Ana-
dc.contributor.authorChen, Zhibin-
dc.contributor.authorKwan, Patrick-
dc.date2022-
dc.date.accessioned2023-01-12T04:57:58Z-
dc.date.available2023-01-12T04:57:58Z-
dc.date.issued2023-01-
dc.identifier.citationCNS Drugs 2023; 37(1)en_US
dc.identifier.issn1179-1934-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/31873-
dc.description.abstractUnderstanding the multi-faceted treatment outcomes of newly diagnosed epilepsy is critical for developing rational therapeutic strategies. A meta-analysis was conducted to derive pooled estimates of a range of seizure outcomes in children and adults with newly diagnosed epilepsy commenced on antiseizure medication treatment, and to identify factors associated with different outcomes.en_US
dc.language.isoeng-
dc.titleTreatment Outcomes of Newly Diagnosed Epilepsy: A Systematic Review and Meta-analysis.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleCNS Drugsen_US
dc.identifier.affiliationDepartment of Neuroscience, Central Clinical School, The Alfred Centre, Monash University, Level 6, 99 Commercial Road, Melbourne, VIC, 3004, Australia.en_US
dc.identifier.affiliationDepartment of Neuroscience, Central Clinical School, The Alfred Centre, Monash University, Level 6, 99 Commercial Road, Melbourne, VIC, 3004, Australia.en_US
dc.identifier.affiliationDepartment of Neurology, The Royal Melbourne Hospital, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationDepartment of Medicine, The University of Melbourne, Melbourne, VIC, Australia.en_US
dc.identifier.affiliationComprehensive Epilepsy Programen_US
dc.identifier.doi10.1007/s40263-022-00979-1en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0001-8601-3686en_US
dc.identifier.orcid0000-0001-7310-276Xen_US
dc.identifier.pubmedid36542274-
dc.description.volume37-
dc.description.issue1-
dc.description.startpage13-
dc.description.endpage30-
dc.subject.meshtermssecondaryAnticonvulsants/therapeutic use-
dc.subject.meshtermssecondaryEpilepsy/drug therapy-
dc.subject.meshtermssecondarySeizures/drug therapy-
local.name.researcherPerucca, Piero
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.cerifentitytypePublications-
crisitem.author.deptNeurology-
crisitem.author.deptComprehensive Epilepsy Program-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Nov 8, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.